The Scientist - Home

The introduced cells engrafted in the nose, became olfactory sensory neurons, and sent axons to the animals’ brains.

A rogue hybrid lymphocyte, bearing characteristics of both B and T cells, may play a role in driving autoimmunity in the disease, although the mechanism is far from clear.

Emails reveal that a facility in Dubai and others have asked geneticist He Jiankui for help in gene-editing embryos.

The second phase of the Human Microbiome Project reports on microbial composition in prediabetes, inflammatory bowel disease, and pregnancy.

Executives at a biotech that develops new antibodies argue that Ram Sasisekharan didn’t come up with the structures for at least two experimental therapies that his group has described.

Observers expect that the National Labor Relations Board will reverse an Obama-era determination that graduate students are employees entitled to form unions.

A comparison of thousands of former athletes in the two sports finds that NFL players were more likely than MLB players to die from cardiovascular and neurodegenerative diseases, in particular.

Silver birch, elder, and yew win out in an experiment to see which species best capture the tiny particles from diesel pollution.

At $2 million for a single dose, Novartis’s Zolgensma is the most expensive medicine to date, but still less expensive over a lifetime than another approved drug for the rare genetic disease.

The chemical process may make the metal more soluble and move it closer to the Earth’s surface.

Patients in a study of catheter ablation who showed signs of more injury to nerve cells and glia in the heart had fewer symptoms after the treatment.

This marks the second known instance in which an institution has acted on NIH’s concern about foreign influence over US-based researchers.